# Adaptimmune Therapeutics PLC: Form 8-K, filed May 30, 2024

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2024-05-30
- Accepted by EDGAR: May 30, 2024, 16:09 ET
- Period: 2024-05-30
- Accession: 0001558370-24-008778
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000155837024008778/adap-20240530x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000155837024008778/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000155837024008778/adap-20240530x8k.htm

Filed May 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-008778. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.